Following this treatment response, the Sox2+ cells were capable of rapidly reentering the cell cycle and generating a rapidly proliferating recurrent tumor, a behavior comparable to NEPs in the developing cerebellum, which can reenter the cell cycle following injury.30 These findings emphasize the need to use therapeutic approaches that can effectively eliminate quiescent Sox2+ cells to prevent recurrence. This evidence concerns the gene SOX2 and neoplasm.